BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 34907501)

  • 1. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Bhatia R; Sharma A; Narang RK; Rawal RK
    Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
    Kumar A; Huo S; Zhang X; Liu J; Tan A; Li S; Jin S; Xue X; Zhao Y; Ji T; Han L; Liu H; Zhang X; Zhang J; Zou G; Wang T; Tang S; Liang XJ
    ACS Nano; 2014 May; 8(5):4205-20. PubMed ID: 24730557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances and prospects in gemcitabine drug delivery systems.
    Paroha S; Verma J; Dubey RD; Dewangan RP; Molugulu N; Bapat RA; Sahoo PK; Kesharwani P
    Int J Pharm; 2021 Jan; 592():120043. PubMed ID: 33152476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Kapalatiya H; Madav Y; Tambe VS; Wairkar S
    Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer.
    Naz S; Shamoon M; Wang R; Zhang L; Zhou J; Chen J
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based chemotherapy
    Xian C; Chen H; Xiong F; Fang Y; Huang H; Wu J
    Biomater Sci; 2021 Sep; 9(18):6023-6036. PubMed ID: 34323260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
    Zhang S; Sun J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics.
    Sarkar M; Wang Y; Ekpenyong O; Liang D; Xie H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1846. PubMed ID: 35979879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-targeted nanocarriers for therapeutic delivery to cancer.
    Yu B; Tai HC; Xue W; Lee LJ; Lee RJ
    Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation.
    Kaur J; Gulati M; Jha NK; Disouza J; Patravale V; Dua K; Singh SK
    Drug Discov Today; 2022 May; 27(5):1495-1512. PubMed ID: 35158056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Nanoparticles for Anticancer Drug Delivery: A Review.
    Zhu Y; Liao L
    J Nanosci Nanotechnol; 2015 Jul; 15(7):4753-73. PubMed ID: 26373036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E; Horodecka K; Shcharbin D; Bryszewska M
    Curr Med Chem; 2021; 28(2):346-359. PubMed ID: 32000637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarriers based novel and effective drug delivery system.
    Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A
    Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
    Phillips MC; Mousa SA
    Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.